• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结中氟脱氧葡萄糖摄取最高可预测局部晚期鼻咽癌患者的无远处转移生存。

Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.

机构信息

From the Departments of Nuclear Medicine, and.

Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Clin Nucl Med. 2018 Jul;43(7):e220-e225. doi: 10.1097/RLU.0000000000002145.

DOI:10.1097/RLU.0000000000002145
PMID:29762247
Abstract

PURPOSE

Distant failure is a major concern in patients with nasopharyngeal carcinoma. We evaluated whether the metabolic features on F-FDG PET/CT can predict distant metastasis-free survival (DMFS) in patients with locally advanced nasopharyngeal carcinoma.

METHODS

We retrospectively reviewed 51 patients stage III, IVA, and IVB nasopharyngeal carcinoma who underwent F-FDG PET/CT at staging. The SUVmax for the primary site and the lymph nodes with the highest uptake as well as at the farthest station were divided by the SUVmean of the background liver (TLR, NLR-H, and NLR-F, respectively). The prognostic value of clinicopathologic factors and SUV parameters for predicting DMFS were assessed using a Cox proportional hazards model. Differences in DMFS were examined by the Kaplan-Meier method.

RESULTS

In the median follow-up period of 50.4 ± 39.3 months (median ± interquartile range; range, 3.8-130.9), distant metastasis developed in 11 patients (21.6%). In univariate analyses, N stage (N3b) (P = 0.003) and NLR-H >5.70 (P = 0.02) were significant prognostic factors for DMFS, and remained significant in multivariate analysis, whereas TLR (P = 0.18) and NLR-F (P = 0.76) did not. The Kaplan-Meier curves showed significantly poorer DMFS in patients with NLR-H >5.70 than in those with lower NLR-H (≤5.70) (1-year DMFS rate, 84.2% vs 93.5%; P = 0.01).

CONCLUSIONS

In addition to anatomical N stage, higher NLR-H on pretreatment F-FDG PET/CT is an independent prognostic factor for worse DMFS in patients with locally advanced nasopharyngeal carcinoma.

摘要

目的

远处失败是鼻咽癌患者的主要关注点。我们评估了 F-FDG PET/CT 的代谢特征是否可以预测局部晚期鼻咽癌患者的无远处转移生存(DMFS)。

方法

我们回顾性分析了 51 例分期时接受 F-FDG PET/CT 检查的 III、IVA 和 IVB 期鼻咽癌患者。原发灶和摄取最高的淋巴结以及最远部位的 SUVmax 分别除以背景肝脏的 SUVmean(分别为 TLR、NLR-H 和 NLR-F)。使用 Cox 比例风险模型评估临床病理因素和 SUV 参数对预测 DMFS 的预后价值。通过 Kaplan-Meier 方法检查 DMFS 的差异。

结果

在中位数为 50.4±39.3 个月(中位数±四分位距;范围,3.8-130.9)的中位随访期间,11 例(21.6%)患者发生远处转移。在单因素分析中,N 分期(N3b)(P=0.003)和 NLR-H>5.70(P=0.02)是 DMFS 的显著预后因素,多因素分析中仍然显著,而 TLR(P=0.18)和 NLR-F(P=0.76)则不然。Kaplan-Meier 曲线显示 NLR-H>5.70 的患者 DMFS 明显较差,低于 NLR-H 较低的患者(≤5.70)(1 年 DMFS 率,84.2%比 93.5%;P=0.01)。

结论

除了解剖 N 分期外,治疗前 F-FDG PET/CT 上的 NLR-H 较高是局部晚期鼻咽癌患者 DMFS 较差的独立预后因素。

相似文献

1
Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.淋巴结中氟脱氧葡萄糖摄取最高可预测局部晚期鼻咽癌患者的无远处转移生存。
Clin Nucl Med. 2018 Jul;43(7):e220-e225. doi: 10.1097/RLU.0000000000002145.
2
Lymph node standardized uptake values at pre-treatment F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.治疗前F-氟脱氧葡萄糖正电子发射断层扫描中的淋巴结标准化摄取值作为鼻咽癌远处转移的重要预后因素。
Br J Radiol. 2017 Mar;90(1071):20160239. doi: 10.1259/bjr.20160239. Epub 2016 Dec 23.
3
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.结合血浆爱泼斯坦-巴尔病毒DNA和18F-氟-2-脱氧-D-葡萄糖正电子发射断层扫描的淋巴结最大标准摄取值,可改善预后分层,以预测局部晚期鼻咽癌的远处转移。
Oncotarget. 2015 Nov 10;6(35):38296-307. doi: 10.18632/oncotarget.5699.
4
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.建立一个整合标准化摄取值和N分期的综合模型以预测鼻咽癌转移
Oncotarget. 2016 Mar 22;7(12):13612-20. doi: 10.18632/oncotarget.7253.
5
Prognostic value of primary gross tumor volume and standardized uptake value of F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.PET/CT中F-FDG的原发肿瘤大体体积和标准化摄取值对局部区域晚期鼻咽癌远处转移的预后价值。
Tumour Biol. 2017 Jul;39(7):1010428317717843. doi: 10.1177/1010428317717843.
6
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.治疗前 18F-FDG PET/CT 最大标准化摄取值对局部晚期头颈部鳞状细胞癌的预后价值。
Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.
7
Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.(18)F-FDG PET-CT 在前瞻性和同期放化疗鼻咽癌中的预后价值:颈部淋巴结是一个有用的预后影像学生物标志物部位。
Radiother Oncol. 2016 Jul;120(1):87-91. doi: 10.1016/j.radonc.2016.05.021. Epub 2016 Jun 16.
8
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.18F-FDG PET参数在晚期鼻咽癌患者中的临床应用:对不同生存终点的预测作用及对预后分层的影响
Nucl Med Commun. 2011 Nov;32(11):989-96. doi: 10.1097/MNM.0b013e3283495662.
9
The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.治疗局部晚期鼻咽癌前淋巴结标准摄取值与原发肿瘤比值的预后价值。
Eur Arch Otorhinolaryngol. 2023 Jan;280(1):347-356. doi: 10.1007/s00405-022-07562-w. Epub 2022 Aug 6.
10
Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.原发肿瘤和颈部淋巴结 18F-FDG PET 摄取标准化值作为鼻咽癌患者远处转移预测因子的研究。
Oral Oncol. 2013 Feb;49(2):169-74. doi: 10.1016/j.oraloncology.2012.08.011. Epub 2012 Oct 12.

引用本文的文献

1
Spectral computed tomography parameters of primary tumors and lymph nodes for predicting tumor deposits in colorectal cancer.用于预测结直肠癌中肿瘤沉积物的原发性肿瘤和淋巴结的光谱计算机断层扫描参数
World J Radiol. 2025 Apr 28;17(4):103359. doi: 10.4329/wjr.v17.i4.103359.
2
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.新诊断转移性鼻咽癌患者化疗及同期放化疗后,治疗前 FDG PET/CT SUVmax 对转移灶的预后价值。
Cancer Imaging. 2023 Feb 24;23(1):21. doi: 10.1186/s40644-023-00536-z.
3
Reflecting on the utility of standardized uptake values on F-FDG PET in nasopharyngeal carcinoma.
反思 F-FDG PET 标准化摄取值在鼻咽癌中的应用价值。
BMC Cancer. 2022 May 5;22(1):495. doi: 10.1186/s12885-022-09626-w.
4
Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma.用于指导 T3N1M0 期鼻咽癌个体化诱导化疗的放射学评分的制定与验证。
Eur Radiol. 2022 Jun;32(6):3649-3660. doi: 10.1007/s00330-021-08460-1. Epub 2022 Jan 6.
5
Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.预测鼻咽癌调强放疗后远处转移的预后列线图。
Medicine (Baltimore). 2021 Nov 24;100(47):e27947. doi: 10.1097/MD.0000000000027947.
6
Improving the Prognostic Performance of SUV in F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Using Tumor-to-Liver and Tumor-to-Blood Standard Uptake Ratio for Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy.利用肿瘤与肝脏及肿瘤与血液的标准摄取值比提高氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描中SUV对同步放化疗治疗的局部晚期宫颈癌的预后评估性能
J Clin Med. 2020 Jun 16;9(6):1878. doi: 10.3390/jcm9061878.
7
PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.正电子发射断层扫描/计算机断层扫描(PET/CT)特征可区分新诊断的非小细胞肺癌患者中单个骨 FDG 摄取病灶转移的风险。
Eur Radiol. 2019 Apr;29(4):1903-1911. doi: 10.1007/s00330-018-5764-9. Epub 2018 Oct 12.